ME
PT Merck Tbk
MERK.JK · JKT
Rp 3,910.00 +0.77% (+Rp 30.00)
1M -2.76%
Market Cap Rp 1.73T
P/E Ratio 5.20x
Div. Yield -
ROE 34.94%
Bulios Fair Price
Rp 4,325
10.6% upside
Current Price
Rp 3,910
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MERK.JK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
99 /100
Cheap P/B 1.80x
P/S 1.28x
P/E 5.20x
Growth
62 /100
Stable Book val. growth 8.82%
FCF growth 28.95%
EPS growth 10.69%
Profitability
100 /100
Strong FCF margin 22.22%
Op. margin 32.39%
Gross margin 49.55%
Quality
99 /100
Excellent Asset turnover 1.10x
ROA 27.14%
ROIC 31.68%
Debt
100 /100
Low Net debt/EBITDA -0.66x
Int. coverage 189.48x
Debt/Equity 0.02x
Stability
52 /100
Moderate Profitable years 6
EPS volatility 38.84%
Beta 0.17x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MERK.JK
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Evie Yulin
Employees
358
Headquarters
Jakarta Timur